pharma · Triple-Negative Breast Cancer (TNBC) · TELO
Telomir Pharmaceuticals
Telomir Pharmaceuticals drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Tampa, USA HQ
2022 Founded
6 Employees
Public company Type
TELO · NYSE Ticker
Company details
- Status
- Public
- HQ
- Tampa, USA
- Founded
- 2022
- Employees
- 6
- Programs
- 1
- Drugs
- 0
- Patents
- 0
Telomir Pharmaceuticals pipeline
Portfolio lens on 0 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Telomir Pharmaceuticals drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.